Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02795637 · ClinicalTrials.gov registry record · Phase 1
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
A Phase 1 study, sponsored by Sumitomo Pharma America.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
NCT02795637: Completed Phase 1 study, sponsored by Sumitomo Pharma America.
NCT02795637 is a Phase 1 study that has completed, run by Sumitomo Pharma America. The registered enrollment target is 44 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02795637, a Phase 1 study, has completed, sponsored by Sumitomo Pharma America.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
Study of the what the body does to the drug in subjects with mild, moderate, and sever liver dysfunction (not working properly)
Primary Outcome
Plasma PK parameters: Area under the plasma/serum concentration-time curve from time zero to infinity (AUC0 inf)
Interventions
- DRUG dasotraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-11 |
| Phase | Phase 1 |
What the finished NCT02795637 record still lists
NCT02795637 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (27% lower).
The record links to 0 conditions, and to 1 intervention - of which dasotraline is the first listed.
NCT02795637 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02795637 about?
NCT02795637 is a clinical study titled "Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction". Study of the what the body does to the drug in subjects with mild, moderate, and sever liver dysfunction (not working properly)
What is the current status of trial NCT02795637?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2016-05. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02795637?
The interventions under investigation include: dasotraline (DRUG).
Who is sponsoring clinical trial NCT02795637?
This trial is sponsored by Sumitomo Pharma America, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02795637's enrollment target sits among peer trials
44 1086th of 2000 higher than 901 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia